(Q33900462)

29 July 2017

Protamine and protamine-insulins exacerbate the vascular response to injury (English)

1 reference

29 July 2017

E R Edelman

1

1 reference

29 July 2017

L A Pukac

series ordinal

2

1 reference

29 July 2017

M J Karnovsky

series ordinal

3

1 reference

29 July 2017

language of work or name

English

0 references

publication date

1 May 1993

1 reference

Journal of Clinical Investigation

29 July 2017

1 reference

29 July 2017

91

1 reference

29 July 2017

5

1 reference

29 July 2017

2308-2313

1 reference

The effect of alloxan diabetes on experimental cholesterol atherosclerosis in the rabbit. III. The mechanism of the inhibition of experimental cholesterol atherosclerosis in alloxan-diabetic rabbits

29 July 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=288236

The effect of alloxan diabetes on experimental cholesterol atherosclerosis in the rabbit. IV. The effect of insulin therapy on the inhibition of atherosclerosis in the alloxan-diabetic rabbit

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=288236

Cultured endothelial cells produce heparinlike inhibitor of smooth muscle cell growth

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=288236

Chemotaxis of monocytes and neutrophils to platelet-derived growth factor

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=288236

Platelet-derived growth factor. Specific binding to target cells

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=288236

Protamine inhibits platelet derived growth factor receptor activity but not epidermal growth factor activity

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=288236

Controlled release and magnetically modulated release systems for macromolecules.

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=288236

Partial reversal of low molecular weight heparin (PK 10169) anti-Xa activity by protamine sulfate: in vitro and in vivo study during cardiac surgery with extracorporeal circulation

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=288236

Structural determinants of the capacity of heparin to inhibit the proliferation of vascular smooth muscle cells. II. Evidence for a pentasaccharide sequence that contains a 3-O-sulfate group

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=288236

An antiproliferative heparan sulfate species produced by postconfluent smooth muscle cells

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=288236

Inhibition of heparanase-mediated degradation of extracellular matrix heparan sulfate by non-anticoagulant heparin species

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=288236

Serious adverse reactions to protamine sulfate: are alternatives needed?

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=288236

Proteoglycans and vascular cell proliferation

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=288236

Quantitative in-vivo studies on angiogenesis in a rat sponge model

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=288236

Heparin modulates the composition of the extracellular matrix domain surrounding arterial smooth muscle cells

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=288236

Effect of controlled adventitial heparin delivery on smooth muscle cell proliferation following endothelial injury

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=288236

Neutralization of low molecular weight heparin by polybrene prevents thromboxane release and severe pulmonary hypertension in awake sheep

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=288236

Thromboxane receptor blockade prevents pulmonary hypertension induced by heparin-protamine reactions in awake sheep

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=288236

Enforced BCL2 expression in B-lymphoid cells prolongs antibody responses and elicits autoimmune disease

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=288236

Cell surface, heparin-like molecules are required for binding of basic fibroblast growth factor to its high affinity receptor

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=288236

Platelet factor 4 efficiently reverses heparin anticoagulation in the rat without adverse effects of heparin-protamine complexes

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=288236

Heparin selectively inhibits the transcription of tissue-type plasminogen activator in primate arterial smooth muscle cells during mitogenesis

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=288236

The mechanism of alloxan protection in experimental atherosclerosis

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=288236

Kinetics of cellular proliferation after arterial injury. I. Smooth muscle growth in the absence of endothelium.

29 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=288236

Circulating IgG antibody to protamine in patients treated with protamine-insulins

29 October 2018

1 reference

12 December 2020

Inhibition of rat arterial smooth muscle cell proliferation by heparin. In vivo studies with anticoagulant and nonanticoagulant heparin

1 reference

12 December 2020

Comparative Neutralization of Lung‐and Mucosal‐Derived Heparin by Protamine Sulfate Using In Vitro and In Vivo Methods

1 reference

12 December 2020

Sequential degradation of heparan sulfate in the subendothelial extracellular matrix by highly metastatic lymphoma cells

1 reference

12 December 2020

Neutralization of heparin by protamine. Time for a change?

1 reference

12 December 2020

Modulation of mitogenic activity and cellular binding of basic fibroblast growth factor by basic proteins

1 reference

12 December 2020

The influence of alloxan diabetes on cholesterol atheromatosis in the rabbit

1 reference

12 December 2020

Increased risk of severe protamine reactions in NPH insulin-dependent diabetics undergoing cardiac catheterization

1 reference

12 December 2020

Protamine is an inhibitor of angiogenesis

1 reference

12 December 2020

Suppression by heparin of smooth muscle cell proliferation in injured arteries

1 reference

12 December 2020

Restenosis after percutaneous transluminal coronary angioplasty (PTCA): A report from the PTCA registry of the national heart, lung, and blood institute

1 reference

12 December 2020

Rainbow trout protamines. Amino acid sequences of six distinct proteins from a single testis

1 reference

12 December 2020

Recurrence of stenoses after coronary angioplasty

1 reference

12 December 2020

Effect of heparin on vascular smooth muscle cells. I. Cell metabolism

1 reference

12 December 2020

Biochemical and pharmacologic studies on the protamine interactions with heparin, its fractions and fragments

1 reference

12 December 2020

Structure-activity relationship in heparin: a synthetic pentasaccharide with high affinity for antithrombin III and eliciting high anti-factor Xa activity

1 reference

12 December 2020

Protamine sulfate inhibits mitogenic activities of the extracellular matrix and fibroblast growth factor, but potentiates that of epidermal growth factor

1 reference

12 December 2020

Identifiers

DOI

10.1172/JCI116460

1 reference

29 July 2017

1 reference

29 July 2017

1 reference